ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo

Luke, Thomas*; Wu, Hua; Zhao, Jincun; Channappanavar, Rudragouda; Coleman, Christopher M.; Jiao, Jin-An; Matsushita, Hiroaki; Liu, Ye; Postnikova, Elena N.; Ork, Britini L.; Glenn, Gregory; Flyer, David; Defang, Gabriel; Raviprakash, Kanakatte; Kochel, Tadeusz; Wang, Jonathan; Nie, Wensheng; Smith, Gale; Hensley, Lisa E.; Olinger, Gene G.; Kuhn, Jens H.; Holbrook, Michael R.; Johnson, Reed F.; Perlman, Stanley; Sullivan, Eddie; Frieman, Matthew B.广州医学院; 1
Science Translational Medicine2016-2-17DOI: 10.1126/scitranslmed.aaf1061
86被引9阅读
引用收藏
分享

摘要

As of 13 November 2015, 1618 laboratory-confirmed human cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, including 579 deaths, had been reported to the World Health Organization. No specific preventive or therapeutic agent of proven value against MERS-CoV is currently available. Public Health England and the International Severe Acute Respiratory and Emerging Infection Consortium identified passive immunotherapy with neutralizing antibodies as a treatment approach that warrants priority study. Two experimental MERS-CoV vaccines were used to vaccinate two groups of transchromosomic (Tc) bovines that were genetically modified to produce large quantities of fully human polyclonal immunoglobulin G (IgG) antibodies. Vaccination with a clade A gamma-irradiated whole killed virion vaccine (Jordan strain) or a clade B spike protein nanoparticle vaccine (Al-Hasa strain) resulted in Tc bovine sera with high enzyme-linked immunosorbent assay (ELISA) and neutralizing antibody titers in vitro. Two purified Tc bovine human IgG immunoglobulins (Tc hIgG), SAB-300 (produced after Jordan strain vaccination) and SAB-301 (produced after Al-Hasa strain vaccination), also had high ELISA and neutralizing antibody titers without antibody-dependent enhancement in vitro. SAB-301 was selected for in vivo and preclinical studies. Administration of single doses of SAB-301 12 hours before or 24 and 48 hours after MERS-CoV infection (Erasmus Medical Center 2012 strain) of Ad5-hDPP4 receptor-transduced mice rapidly resulted in viral lung titers near or below the limit of detection. Tc bovines, combined with the ability to quickly produce Tc hIgG and develop in vitro assays and animal model(s), potentially offer a platform to rapidly produce a therapeutic to prevent and/or treat MERS-CoV infection and/or other emerging infectious diseases.

学科与关键词

关键词
RESPIRATORY SYNDROME CORONAVIRUSRECEPTOR-BINDING DOMAINHUMAN MONOCLONAL-ANTIBODIESNEUTRALIZING ANTIBODIESSPIKE PROTEINDROMEDARY CAMELSSAUDI-ARABIASARS-COVMICETRANSMISSION
相关
加载中…
  • Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse model
    Zhao, Yongkun; Wang, Chong; Qiu, Boning; Li, Chufang; Wang, Hualei; Jin, Hongli; Gai, Weiwei; Zheng, Xuexing; Wang, Tiecheng; Sun, Weiyang; Yan, Feihu; Gao, Yuwei; Wang, Qian; Yan, Jinghua; Chen, Ling; Penman, Stanley; Zhong, Nanshan; Zhao, Jincun*; Yang, Songtao*; Xia, Xianzhu*Antiviral Research, 2017, 137: 125-130.被引 22
  • Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
    Corti, Davide; Zhao, Jincun; Pedotti, Mattia; Simonelli, Luca; Agnihothram, Sudhakar; Fett, Craig; Fernandez-Rodriguez, Blanca; Foglierini, Mathilde; Agatic, Gloria; Vanzetta, Fabrizia; Gopal, Robin; Langrish, Christopher J.; Barrettg, Nicholas A.; Sallusto, Federica; Baric, Ralph S.; Varani, Luca; Zambon, Maria; Perlman, Stanley; Lanzavecchia, Antonio*PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112(33): 10473-10478.被引 159
  • Passive Immunotherapy with Dromedary Immune Serum in an Experimental Animal Model for Middle East Respiratory Syndrome Coronavirus Infection
    Zhao, Jincun; Perera, Ranawaka A. P. M.; Kayali, Ghazi; Meyerholz, David; Perlman, Stanley*; Peiris, MalikJournal of Virology, 2015, 89(11): 6117-6120.被引 54
查看全部 →

发表信息

论文状态
公开发表
期刊
Science Translational Medicine
发表日期
2016-02-17
卷期
第 8 卷, 第 326 期
页码
326ra21
DOI
10.1126/scitranslmed.aaf1061
语言
ENGLISH
期刊等级
Q1
成果收录
SCIE
资助标注
Global Emerging Infections Surveillance Response System (GEIS) funds work unit [847705.82000.25GB.E0018]; NIH [RO1 AI095569, PO1 AI060699, RO1 AI091322]; Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID); Integrated Research Facility (NIAID, Division of Clinical Research); Battelle Memorial Institute; NIAID [HHSN272200700016I]; Viral and Rickettsial Diseases Department of the Naval Medical Research Center; Henry Jackson Foundation for the Advancement of Military Medicine; U.S. Navy [Omnibus III DO-0005]

作者

  • L

    Luke, Thomas (通讯) (第一作者)

  • W

    Wu, Hua

查看全部 26 位作者收起作者
  • Z

    Zhao, Jincun

    1 · guangzhou med univ

  • C

    Channappanavar, Rudragouda

  • C

    Coleman, Christopher M.

  • J

    Jiao, Jin-An

  • M

    Matsushita, Hiroaki

  • L

    Liu, Ye

  • P

    Postnikova, Elena N.

    nih

  • O

    Ork, Britini L.

    nih

  • G

    Glenn, Gregory

  • F

    Flyer, David

  • D

    Defang, Gabriel

  • R

    Raviprakash, Kanakatte

  • K

    Kochel, Tadeusz

  • W

    Wang, Jonathan

  • N

    Nie, Wensheng

  • S

    Smith, Gale

  • H

    Hensley, Lisa E.

    nih

  • O

    Olinger, Gene G.

    nih

  • K

    Kuhn, Jens H.

    nih

  • H

    Holbrook, Michael R.

    nih

  • J

    Johnson, Reed F.

    nih

  • P

    Perlman, Stanley

  • S

    Sullivan, Eddie

  • F

    Frieman, Matthew B.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417